marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

Klaveness Combination Carriers Orders Fifth Carrier

July 3, 2018

 Norwegian shipping company  Klaveness Combination Carriers (KCC) has declared an option for the construction of a combination carrier with Jiangsu New Yangzi Shipbuilding Co., Ltd in China. 

 
The delivery date is scheduled for second quarter 2020. KCC already has four sister vessels under construction at the same yard with delivery in 2018-2020. 
 
Following the declaration, the KCC fleet will grow to 14 vessels by 2020. The company holds options for further vessels. 
 
"Our fleet of combination carriers and container vessels set standards for efficient and environmentally friendly shipping. Klaveness has a history of developing innovative ship designs, challenging the status quo of sea transport," says the dry bulk owner company.
 
"We are constantly working to improve our fleet, and in addition to our existing fleet below, we are currently developing several new vessel types and shipping concepts," company added.
 
The Issuer of the bond KSH03, Klaveness Ship Holding AS, is the majority owner of KCC.
 

Logistics News

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

ARC Freedom Enters ARC's U.S.-Flagged Fleet

ARC Freedom Enters ARC's U.S.-Flagged Fleet

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

Subscribe for Maritime Logistics Professional E‑News

Saudi Aramco is planning a reorganisation that will create a gas division, according to sources.
Sources say that traders are pushing for lower prices for Venezuelan crude oil, as shipping costs have risen.
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry